China Biologic Products (CBPO)

Add to Watchlists Create an Alert
26.50 +0.10  +0.38%   NASDAQ May 23, 8:00PM BATS Real time Currency in USD

China Biologic Products Current Ratio:

4.656 for Dec. 31, 2012
View Full Chart

China Biologic Products Current Ratio Chart

    China Biologic Products Historical Current Ratio Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 4.656
    Sept. 30, 2012 3.937
    June 30, 2012 4.801
    March 31, 2012 3.504
    Dec. 31, 2011 2.708
    Sept. 30, 2011 2.855
    June 30, 2011 2.338
    March 31, 2011 1.810
    Dec. 31, 2010 1.859
    Sept. 30, 2010 2.565
    June 30, 2010 2.421
       
    March 31, 2010 1.977
    Dec. 31, 2009 1.139
    Sept. 30, 2009 1.441
    June 30, 2009 1.264
    March 31, 2009 1.034
    Dec. 31, 2008 1.331
    Sept. 30, 2008 2.247
    June 30, 2008 2.499
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro

    About Current Ratio

    The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. The ratio illustrates a company's ability to remain solvent.

    A current ratio of one means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning current assets twice as large as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.

    Other similar solvency ratios include :
    Cash Ratio - Measures the amount of cash that can be used to pay liabilities (most strict)
    Quick Ratio - Measures the amount of cash, short term equivalents, and accounts receivables that can be used to pay liabilities (more lenient than cash ratio, but stricter than current ratio)
    Learn More

    Get data for

    CBPO Current Ratio Benchmarks

    Companies
    Acorda Therapeutics 4.083
    Vanda Pharmaceuticals 3.904
    Theravance 16.10

    CBPO Current Ratio Rankings

    Overall 88th percentile
    897 of 8006
    Sector 71st percentile
    194 of 686 in Healthcare
    Industry 59th percentile
    101 of 248 in Biotechnology

    CBPO Current Ratio Range, Past 5 Years

    Minimum 1.034 Mar 2009
    Maximum 4.801 Jun 2012
    Average 2.441